Yiqi Pan
Yiqi Pan
M. Sc.
  • Wissenschaftliche Mitarbeiterin



W37 , 6. Etage
Deutsch (Muttersprache)




Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis
Meister R, Abbas M, Antel J, Peters T, Pan Y, Bingel U, Nestoriuc Y, Hebebrand J
EUR CHILD ADOLES PSY. 2020;29(3):253-273.


Substance Abuse-Related Self-Stigma in Women with Substance Use Disorder and Comorbid Posttraumatic Stress Disorder
Melchior H, Hüsing P, Grundmann J, Lotzin A, Hiller P, Pan Y, Driessen M, Scherbaum N, Schneider B, Hillemacher T, Stolzenburg S, Schomerus G, Schäfer I
EUR ADDICT RES. 2019;25(1):20-29.

Minimizing Drug Adverse Events by Informing About the Nocebo Effect—An Experimental Study
Pan Y, Kinitz T, Stapic M, Nestoriuc Y
Front Psychiatry. 2019;10(10):504.

Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial
Pan Y, Meister R, Löwe B, Winkelmann A, Kaptchuk T, Bühling K, Nestoriuc Y
TRIALS. 2019;20(1):508.


Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study
Pan Y, Heisig S, von Blanckenburg P, Albert U, Hadji P, Rief W, Nestoriuc Y
BREAST CANCER RES TR. 2018;168(3):667-677.

Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients
Quidde J, Pan Y, Salm M, Hendi A, Nilsson S, Oechsle K, Stein A, Nestoriuc Y
BMC CANCER. 2018;18(1):916.

Letzte Aktualisierung aus dem FIS: 31.05.2020 - 05:23 Uhr